From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

ShareProphets Share Tip of the Week: Buy Hutchison China Meditech at an 870p offer

By ShareProphets | Sunday 15 June 2014


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Investment Case: Majority owned by Hutchison Whampoa, the Hong Kong-listed renowned multinational infrastructure, property, retail and telecommunications conglomerate including the likes of the ‘3’ mobile business, Hutchison China MediTech (HCM) is the holding company of a primarily China-based healthcare and drug development group. This includes growing businesses selling already established products and a drug research & development business which has developed strongly and looks to offer vast upside potential. This combination makes the shares a buy at an 870p offer price.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

ANP

Anpario – a recovery Buy?...

Thursday »

Cat_Fixing_Lightbulb

Bearcast issue update: all should be well

 

ORCP

Oracle Power: Cynical Foul

Time left: 08:25:02